Company news

Introducing ComplEYE Drops™ MDB

Now joining our family of top-selling combination drops, Pine Pharmaceuticals is excited to announce our all-new 3 in 1 post-op drop ComplEYE Drops™ MDB (Moxifloxacin 0.5%–Dexamethasone 0.1%–Bromfenac 0.035%). This easy-to-manage solution combines an antibiotic,...

MasterControl Award: Excellence in Analytics

We're excited to announce that Pine Pharmaceuticals has been honored with the Excellence in Analytics award by MasterControl.  Spearheaded by our Innovation and Development Manager, James Ando, Pharm.D., MasterControl has been pivotal in transforming our reports into...

Pine Pharmaceuticals wins Brick by Brick Award

We're thrilled to announce that Buffalo Business First awarded Pine Pharmaceuticals a Brick by Brick award, recognizing our 50,000-square-foot expansion. These exclusive awards highlight the accomplishments of Western New York's real estate development industry. Thank...

Introducing StaClear® Luer Slip and Norm-Ject® Less Fill

Pine Pharmaceuticals is pleased to introduce StaClear® Luer Slip and NORM-JECT® Less Fill, our all-new syringe options for repackaged bevacizumab. Designed to provide exceptional quality, StaClear® Luer Slip and NORM-JECT® Less Fill syringes now offer a low dead space...